Key terms

About PHR

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest PHR news

Apr 11 4:55am ET Phreesia management to meet with KeyBanc Apr 10 4:06pm ET Phreesia management to meet with KeyBanc Apr 09 7:36am ET Truist Financial Reaffirms Their Buy Rating on Phreesia (PHR) Apr 05 6:47am ET Piper Sandler Sticks to Their Buy Rating for Phreesia (PHR) Mar 21 7:10am ET Analysts Offer Insights on Healthcare Companies: Phreesia (PHR) and OmniAb (OABI) Mar 21 6:07am ET Phreesia price target raised to $30 from $28 at JMP Securities Mar 21 3:45am ET Phreesia (PHR) Gets a Buy from JMP Securities Mar 19 12:07pm ET Phreesia management to meet virtually with DA Davidson Mar 19 6:52am ET Phreesia names Jack Callahan as new Chief Technology Officer Mar 19 4:55am ET Phreesia management to meet with JMP Securities Mar 18 12:51pm ET Phreesia management to meet with JMP Securities Mar 18 7:14am ET Phreesia price target raised to $31 from $30 at Baird Mar 17 2:01am ET Phreesia’s Indian Expansion: Navigating Risks in a Dynamic Market Mar 15 9:42am ET Phreesia price target raised to $23 from $17 at RBC Capital Mar 15 7:20am ET Phreesia price target raised to $37 from $36 at Canaccord Mar 14 4:04pm ET Phreesia backs FY25 revenue view $424M-$434M, consensus $428.12M Mar 14 4:04pm ET Phreesia reports Q4 EPS (56c), consensus (26c) Mar 13 3:55am ET KeyBanc Sticks to Their Buy Rating for Phreesia (PHR) Mar 12 8:38am ET Truist Financial Sticks to Its Buy Rating for Phreesia (PHR) Mar 12 12:55am ET Phreesia (PHR) Receives a Buy from JMP Securities Mar 07 4:46am ET Barclays Sticks to Their Buy Rating for Phreesia (PHR) Feb 26 6:17am ET Buy Rating Affirmed for Phreesia on Strong Growth and Market Expansion Potential Feb 26 6:05am ET Phreesia initiated with a Buy at Truist Jan 22 1:50pm ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), RegenXBio (RGNX) and ESSA Pharma (EPIX) Jan 16 4:07pm ET Phreesia upgraded to Buy from Neutral at DA Davidson

No recent news articles are available for PHR

No recent press releases are available for PHR

PHR Financials

1-year income & revenue

Key terms

PHR Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

PHR Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms